BioSpace News Archive

Evofem Biosciences, Inc., reported financial results for the three-month period ended March 31, 2022.

BIOLASE, Inc. announced that it will release first quarter 2022 financial and operating results on Thursday, May 12, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m.

Mediso Ltd today announced the acquisition of Bartec Technologies Ltd, UK based company specialised in the supply, installation and support of Nuclear Medicine and Molecular Imaging equipment and accessories.

Abbott announced it has received FDA clearance for its Alinity™ m STI Assay.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today announced that Purnovate, Inc., has entered into a research collaboration agreement with the University of California San Diego (UC San Diego), to further evaluate the Company’s proprietary adenosine analogs as a potential treatment for inflammatory diseases, including inflammatory bowel disease (IBD) and infectious diseases where a large immune response (i.e., cytokine storm) plays a significant role.

Alamar Biosciences (Alamar), and Mologic, Ltd. (Mologic), today announced a collaboration to utilize Alamar’s novel antibodies against SARS-CoV-2 Nucleocapsid (N) protein for Mologic’s future COVID-19 RDTs.

Today AriBio Co., Ltd. announced the completion of the end of phase 2 meeting (EOP2) with the United States Food and Drug Administration (FDA), Division of Neurology 1.

Brand Institute is proud to announce working with rare disease specialist, Orphalan, in developing the brand name CUVRIOR™, approved by the United States Food and Drug Administration on April 28, 2022.

The global intraocular lens market was estimated at USD 3.9 billion in 2020 and is predicted to hit around USD 6.1 billion by 2030 with a CAGR of 4.7% during the forecast period 2022 to 2030.

The global Mammography market was estimated at US$ 11.43 billion in 2020 and is expected to hit around US$ 13.8 billion by 2030, growing at a CAGR of 21.5% from 2021 to 2030.